Definitive Healthcare Corp. (DH) stock
DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3069% below fair value
$1.25−0.03 (-2.34%)
Close on Nov 12, 2026Market cap $133.43MP/E –Yield –
Definitive Healthcare ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Definitive Healthcare's ebitda for the twelve months ending Sep 30, 2026 was -$220.30M. For fiscal 2025 it was -$220.97M. The highest annual figure on record is -$14.73M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$220.97M | – |
| FY2024 | Dec 31, 2024 | -$708.58M | – |
| FY2023 | Dec 31, 2023 | -$327.85M | – |
| FY2022 | Dec 31, 2022 | -$41.85M | – |
| FY2021 | Dec 31, 2021 | -$25.57M | – |
| FY2020 | Dec 31, 2020 | -$14.73M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.83M | +886.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.79M | -62.9% |
| Q1 FY2026 | Mar 31, 2026 | -$200.29M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.64M | – |
| Q3 FY2025 | Sep 30, 2025 | $388.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $4.83M | – |
| Q1 FY2025 | Mar 31, 2025 | -$184.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$99.04M | – |
| Q1 FY2024 | Jun 30, 2024 | -$384.73M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.52M | – |
| Q3 FY2023 | Sep 30, 2023 | -$285.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.38M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$497.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$25.00K | -100.5% |
| Q2 FY2022 | Jun 30, 2022 | -$1.68M | -163.5% |
| Q1 FY2022 | Mar 31, 2022 | -$11.04M | -261.8% |
| Q4 FY2021 | Dec 31, 2021 | -$3.23M | -219.4% |
| Q3 FY2021 | Sep 30, 2021 | $5.12M | -42.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.65M | -64.5% |
| Q1 FY2021 | Mar 31, 2021 | $6.82M | +29.9% |
| Q4 FY2020 | Dec 31, 2020 | $2.71M | – |
| Q3 FY2020 | Sep 30, 2020 | $8.88M | – |
| Q2 FY2020 | Jun 30, 2020 | $7.47M | – |
| Q1 FY2020 | Mar 31, 2020 | $5.25M | – |
See a number that looks wrong?